Infective endocarditis is a grave medical condition marked by inflammation in the inner lining of the heart chambers and valves, known as the endocardium. The inflammation is commonly initiated by the intrusion of bacteria or other infectious agents into the bloodstream, ultimately reaching the heart. The onset of infective endocarditis can be acute or gradual, with symptoms encompassing fever, fatigue, shortness of breath, and an overall sense of malaise. Individuals with pre-existing heart conditions, including congenital heart defects or prosthetic heart valves, face an elevated risk of developing infective endocarditis. Diagnosis necessitates a comprehensive approach, involving clinical assessment, blood tests, and imaging studies to ensure accuracy. Timely identification is imperative, as untreated infective endocarditis can lead to severe complications such as heart valve damage, heart failure, and the formation of infected masses within the heart chambers, known as vegetations.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States